Safety and efficacy after multiple carbon-ion radiotherapy for patients with hepatocellular carcinoma

Safety and efficacy after multiple carbon-ion radiotherapy for patients with hepatocellular carcinoma - Multiple carbon-ion radiotherapy for patients with hepatocellular carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037241

Enrollment

Registered

2019-09-02

Start date

2019-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Carbon-ion radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Biopsy or radiologically proven HCC 2. Measurable lesion on imaging. 3. Eastern Cooperative Oncology Group (ECOG) performance Status 0-2 4. Those patients treated with 2 or 4 fractions of hypofractionated CIRT 5. Tumours which were more than 5mm away from the tubular GI structures

Exclusion criteria

Exclusion criteria: 1. An estimated life expectancy of less than 6 months. 2. Presence of digestive tract within the clinical target volume 3. Medical comorbidities precluding safe administration of re cIRT.

Design outcomes

Primary

Measure	Time frame
Safety after multiple carbon-ion radiotherapy for liver	—

Secondary

Measure	Time frame
Efficacy after multiple carbon-ion radiotherapy for hepatocellular carcinoma	—

Countries

Japan

Contacts

Public ContactGoro Kasuya

National Institutes for Quantum and Radiological Science and Technology QST hospital

kasuya.goro@qst.go.jp043-206-3306

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026